| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. | Song, H; Li, CW ; Labaff, AM; Lim, SO; Li, LY; Kan, SF; Chen, Y; Zhang, K; Lang, J; Xie, X; Wang, Y; Huo, LF; Hsu, SC; Chen, X; Zhao, Y; Hung, MC | Biochemical and biophysical research communications 404(1), 68-73 | | | |
| 2014 | Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells. | Huo, L; Li, CW; Huang, TH; Lam, YC; Xia, W; Tu, C; Chang, WC; Hsu, JL; Lee, DF; Nie, L; Yamaguchi, H; Wang, Y; Lang, J; Li, LY; Chen, CH; Mishra, L; Hung, MC | American journal of translational research 6(6), 649-663 | | | |
| 2018 | Activation of phagocytosis by immune checkpoint blockade. | Li, CW; Lai, YJ; Hsu, JL; Hung, MC | Frontiers of medicine 12(4), 473-480 | | | |
| 2016 | AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. | Li, CW ; Xia, W; Lim, SO; Hsu, JL; Huo, L; Wu, Y; Li, LY; Lai, CC; Chang, SS; Hsu, YH; Sun, HL; Kim, J; Yamaguchi, H; Lee, DF; Wang, H; Wang, Y; Chou, CK; Hsu, JM; Lai, YJ; LaBaff, AM; Ding, Q; Ko, HW; Tsai, FJ; Tsai, CH; Hortobagyi, GN; Hung, MC | Cancer research 76(6), 1451-1462 | | | |
| 2011 | APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. | Ding, Q; Chang, CJ; Xie, X; Xia, W; Yang, JY; Wang, SC; Wang, Y; Xia, J; Chen, L; Cai, C; Li, H; Yen, CJ; Kuo, HP; Lee, DF; Lang, J; Huo, L; Cheng, X; Chen, YJ; Li, CW ; Jeng, LB; Hsu, JL; Li, LY; Tan, A; Curley, SA; Ellis, LM; Dubois, RN; Hung, MC | The Journal of clinical investigation 121(11), 4526-4536 | | | |
| 2013 | Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. | Lin, SP; Lee, YT; Yang, SH; Miller, SA; Chiou, SH; Hung, MC; Hung, SC | CANCER LETTERS 328(2), 226-34 | | | |
| 2014 | Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. | Hsu, YH; Yao, J; Chan, LC; Wu, TJ; Hsu, JL; Fang, YF; Wei, Y; Wu, Y; Huang, WC; Liu, CL; Chang, YC; Wang, MY; Li, CW ; Shen, J; Chen, MK; Sahin, AA; Sood, A; Mills, GB; Yu, D; Hortobagyi, GN; Hung, MC | Cancer research 74(17), 4822-4835 | | | |
| 2018 | Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer. | Shao, B; Li, CW; Lim, SO; Sun, L; Lai, YJ; Hou, J; Liu, C; Chang, CW; Qiu, Y; Hsu, JM; Chan, LC; Zha, Z; Li, H; Hung, MC | American journal of cancer research 8(9), 1837-1846 | | | |
| 2016 | Deubiquitination and Stabilization of PD-L1 by CSN5. | Lim, SO; Li, CW ; Xia, W; Cha, JH; Chan, LC; Wu, Y; Chang, SS; Lin, WC; Hsu, JM; Hsu, YH; Kim, T; Chang, WC; Hsu, JL; Yamaguchi, H; Ding, Q; Wang, Y; Yang, Y; Chen, CH; Sahin, AA; Yu, D; Hortobagyi, GN; Hung, MC | Cancer cell 30(6), 925-939 | | | |
| 2019 | Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. | Zhu, Y; Yang, J; Xu, D; Gao, XM; Zhang, Z; Hsu, JL; Li, CW ; Lim, SO; Sheng, YY; Zhang, Y; Li, JH; Luo, Q; Zheng, Y; Zhao, Y; Lu, L; Jia, HL; Hung, MC; Dong, QZ; Qin, LX | Gut 68(9), 1653-1666 | | | |
| 2022 | Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2 | Chen, HF; Hsueh, PR; Liu, YY; Chen, Y; Chang, SY; Wang, WJ; Wu, CS; Tsai, YM; Liu, YS; Su, WC; Chou, YC ; Hung, MC | American journal of cancer research 12(7), 3333-3346 | | | |
| 2010 | Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. | Su, JL; Chen, PB; Chen, YH; Chen, SC; Chang, YW; Jan, YH; Cheng, X; Hsiao, M; Hung, MC | Cancer Res Jun 15;70(12), 5096-108. Cite 11 | | | |
| 2015 | E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer. | Chen, HA; Chang, YW; Tseng, CF; Chiu, CF; Hong, CC; Wang, W; Wang, MY; Hsiao, M; Ma, JT; Chen, CH; Jiang, SS; Wu, CH; Hung, MC; Huang, MT; Su, JL | Annals of Surgical Oncology 22(3), 889-898 | | | |
| 2014 | EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4. | Chou, RH; Wang, YN; Hsieh, YH; Li, LY; Xia, W; Chang, WC; Chang, LC; Cheng, CC; Lai, CC; Hsu, JL; Chang, WJ; Chiang, SY; Lee, HJ; Liao, HW; Chuang, PH; Chen, HY; Wang, HL; Kuo, SC; Chen, CH; Yu, YL; Hung, MC | Developmental cell 30(2), 224-37 | | | |
| 2016 | EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. | Lim, SO; Li, CW ; Xia, W; Lee, HH; Chang, SS; Shen, J; Hsu, JL; Raftery, D; Djukovic, D; Gu, H; Chang, WC; Wang, HL; Chen, ML; Huo, L; Chen, CH; Wu, Y; Sahin, A; Hanash, SM; Hortobagyi, GN; Hung, MC | Cancer research 76(5), 1284-1296 | | | |
| 2012 | Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. | Li, CW ; Xia, W; Huo, L; Lim, SO; Wu, Y; Hsu, JL; Chao, CH; Yamaguchi, H; Yang, NK; Ding, Q; Wang, Y; Lai, YJ; LaBaff, AM; Wu, TJ; Lin, BR; Yang, MH; Hortobagyi, GN; Hung, MC | Cancer research 72(5), 1290-1300 | | | |
| 2018 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. | Li, CW; Lim, SO; Chung, EM; Kim, YS; Park, AH; Yao, J; Cha, JH; Xia, W; Chan, LC; Kim, T; Chang, SS; Lee, HH; Chou, CK; Liu, YL; Yeh, HC; Perillo, EP; Dunn, AK; Kuo, CW; Khoo, KH ; Hsu, JL; Wu, Y; Hsu, JM; Yamaguchi, H; Huang, TH; Sahin, AA; Hortobagyi, GN; Yoo, SS; Hung, MC | Cancer cell 33(2), 187-201.e10 | | | |
| 2018 | Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. | Yang, Y; Li, CW; Chan, LC; Wei, Y; Hsu, JM; Xia, W; Cha, JH; Hou, J; Hsu, JL; Sun, L; Hung, MC | Cell research 28(8), 862-864 | | | |
| 2011 | FOXO3a dependent mechanism of E1A-Induced chemosensitization. | Su, JL; Cheng, X; Yamaguchi, H; Chang, YW; Hou, CF; Lee, DF; Ko, HW; Hua, KT; Wang, YN; Hsiao, M; Chen, PB; Hsu, JM; Bast, RC; Hortobagyi, GN; Hung, MC | Cancer Res Nov. 1;71(21):6878-6887. Cite 1 | | | |
| 2022 | From polyploidy to polyploidy reversal: its role in normal and disease states. | Wu, CS; Lu, WH; Hung, MC; Huang, YS ; Chao, HW | Trends in genetics : TIG 38(10), 991-995 | | | |
